Literature DB >> 31280471

Contrast-enhanced endoscopic ultrasound diagnosis of the intraductal papillary mucinous neoplasm.

Giovanna Del Vecchio Blanco1, Cristina Gesuale2, Alessandro Anselmo3, Giampiero Palmieri3, Francesca Baciorri4, Monia Di Prete4, Giuseppe Tisone3, Giovanni Monteleone2, Omero Alessandro Paoluzi2.   

Abstract

Pancreatic cystic neoplasms (PCNs) are a frequent incidental finding during an ultrasound or other radiological investigations. As PCNs may have a potential of malignancy, a precise differential diagnosis between a malignant and benign lesion is crucial to define appropriate management of patients with this kind of lesions. Radiology, with computed tomography (CT) and magnetic resonance imaging, may not be conclusive in the diagnostic assessment of PCNs. Endoscopic ultrasound (EUS), a simple and relatively low invasive technique, is able to identify intra-cystic worrisome features suggesting malignancy. Fine-needle aspiration (FNA) of the cystic fluid or of intra-cystic tissue nodule during EUS is an adjunctive procedure for reaching a conclusive diagnosis. As EUS-FNA is burdened by complications, the use of intravenous contrast may increase the diagnostic accuracy of EUS allowing in many cases a correct diagnosis of PCN at high risk of malignancy, without additional risk of complication during the procedure. The present report deals with the case of a cystic lesion found by CT scan in the pancreatic head of a 59-year-old woman suffering from mild epigastric pain. Once submitted to EUS, malignant nature of PCN was suspected due to the finding of a typical worrisome feature, the presence of a mural nodule. The intravenous administration of contrast medium during the EUS confirmed malignancy and the patient was immediately sent to the surgeon for pancreatic resection. Histology revealed an intraductal papillary mucinous neoplasm, with areas of high-grade dysplasia in the main and secondary ducts, progressed toward an invasive carcinoma.

Entities:  

Keywords:  Contrast enhancement; Endoscopic ultrasonography; Intraductal papillary mucinous neoplasm; Pancreatic cystic neoplasm

Year:  2019        PMID: 31280471     DOI: 10.1007/s12328-019-01008-3

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  25 in total

1.  Clinical Impact of KRAS and GNAS Analysis Added to CEA and Cytology in Pancreatic Cystic Fluid Obtained by EUS-FNA.

Authors:  Sandra Faias; Marlene Duarte; Cristina Albuquerque; João Pereira da Silva; Ricardo Fonseca; Ruben Roque; Antonio Dias Pereira; Paula Chaves; Marília Cravo
Journal:  Dig Dis Sci       Date:  2018-05-24       Impact factor: 3.199

2.  The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): update 2011 on non-hepatic applications.

Authors:  F Piscaglia; C Nolsøe; C F Dietrich; D O Cosgrove; O H Gilja; M Bachmann Nielsen; T Albrecht; L Barozzi; M Bertolotto; O Catalano; M Claudon; D A Clevert; J M Correas; M D'Onofrio; F M Drudi; J Eyding; M Giovannini; M Hocke; A Ignee; E M Jung; A S Klauser; N Lassau; E Leen; G Mathis; A Saftoiu; G Seidel; P S Sidhu; G ter Haar; D Timmerman; H P Weskott
Journal:  Ultraschall Med       Date:  2011-08-26       Impact factor: 6.548

3.  Contrast Harmonic-Endoscopic Ultrasound Is Useful to Identify Neoplastic Features of Pancreatic Cysts (With Videos).

Authors:  Pietro Fusaroli; Marta Serrani; Roberto De Giorgio; Maria Cristina D'Ercole; Liza Ceroni; Andrea Lisotti; Giancarlo Caletti
Journal:  Pancreas       Date:  2016-02       Impact factor: 3.327

4.  Italian consensus guidelines for the diagnostic work-up and follow-up of cystic pancreatic neoplasms.

Authors:  Elisabetta Buscarini; Raffaele Pezzilli; Renato Cannizzaro; Claudio De Angelis; Massimo Gion; Giovanni Morana; Giuseppe Zamboni; Paolo Arcidiacono; Gianpaolo Balzano; Luca Barresi; Daniela Basso; Paolo Bocus; Lucia Calculli; Gabriele Capurso; Vincenzo Canzonieri; Riccardo Casadei; Stefano Crippa; Mirko D'Onofrio; Luca Frulloni; Pietro Fusaroli; Guido Manfredi; Donatella Pacchioni; Claudio Pasquali; Rodolfo Rocca; Maurizio Ventrucci; Silvia Venturini; Vincenzo Villanacci; Alessandro Zerbi; Massimo Falconi
Journal:  Dig Liver Dis       Date:  2014-05-05       Impact factor: 4.088

5.  Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study.

Authors:  Toru Furukawa; Günter Klöppel; N Volkan Adsay; Jorge Albores-Saavedra; Noriyoshi Fukushima; Akira Horii; Ralph H Hruban; Yo Kato; David S Klimstra; Daniel S Longnecker; Jutta Lüttges; G Johan A Offerhaus; Michio Shimizu; Makoto Sunamura; Arief Suriawinata; Kyoichi Takaori; Suguru Yonezawa
Journal:  Virchows Arch       Date:  2005-08-09       Impact factor: 4.064

6.  Severe acute pancreatitis after EUS-FNA of a pancreatic cyst: a rare, but serious complication.

Authors:  Els F Jonkman; Bas A C van Tuyl; Floris B M Sanders; Lenneke E M Haas
Journal:  BMJ Case Rep       Date:  2015-05-12

7.  Malignant transformation of branch duct-type intraductal papillary mucinous neoplasms of the pancreas based on contrast-enhanced endoscopic ultrasonography morphological changes: focus on malignant transformation of intraductal papillary mucinous neoplasm itself.

Authors:  Eizaburo Ohno; Akihiro Itoh; Hiroki Kawashima; Takuya Ishikawa; Hiroshi Matsubara; Yuya Itoh; Yosuke Nakamura; Takeshi Hiramatsu; Masanao Nakamura; Ryoji Miyahara; Naoki Ohmiya; Masatoshi Ishigami; Yoshiaki Katano; Hidemi Goto; Yoshiki Hirooka
Journal:  Pancreas       Date:  2012-08       Impact factor: 3.327

8.  Malignant progression in IPMN: a cohort analysis of patients initially selected for resection or observation.

Authors:  J Lafemina; N Katabi; D Klimstra; C Correa-Gallego; S Gaujoux; T P Kingham; R P Dematteo; Y Fong; M I D'Angelica; W R Jarnagin; R K Do; M F Brennan; Peter J Allen
Journal:  Ann Surg Oncol       Date:  2012-10-31       Impact factor: 5.344

9.  Intraductal papillary mucinous neoplasms of the pancreas: differentiation of malignant and benign tumors by endoscopic ultrasound findings of mural nodules.

Authors:  Eizaburo Ohno; Yoshiki Hirooka; Akihiro Itoh; Masatoshi Ishigami; Yoshiaki Katano; Naoki Ohmiya; Yasumasa Niwa; Hidemi Goto
Journal:  Ann Surg       Date:  2009-04       Impact factor: 12.969

10.  European evidence-based guidelines on pancreatic cystic neoplasms.

Authors: 
Journal:  Gut       Date:  2018-03-24       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.